How to Screen and Surveil for Opioid Use Disorder
Wednesday, November 102 p.m. - 3 p.m. ET
Opioid use disorder (OUD) is a major health challenge in the United States, causing both morbidity and mortality—with close to 70,000 opioid overdose deaths in 2020 alone. Having OUD does not discriminate, and thus there is an intersection of chronic pain, serious illness, and palliative care. This means that everyone taking care of patients living with a serious illness will also be taking care of patients at risk for, or with active, OUD.
In this Master Clinician session, Katie Fitzgerald Jones, MSN, APN, and Zachary Sager, MD, will present a case and work through the challenges of screening and surveillance for OUD. They will cover the benefits and limitations of using validated screening tools, and how clinicians can apply a “universal precautions” approach to ensure the safety and quality of life of their patients. Additionally, by the end of the session, participants will understand the intersection of chronic pain, opioid substance use disorder[BM5] , and serious illness.
Katie Fitzgerald Jones, MSN, APN
Zachary Sager, MD